v3.26.1
Deconsolidation (Details Narrative) - USD ($)
 2 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Equity method, net loss   $ (4,282,000)  
Net loss   (21,245,000) $ 11,691,000
Total assets $ 71,976,000 63,740,000 71,976,000
Total liabilities 1,903,000 $ 3,161,000 1,903,000
Exozymes Inc [Member]      
Equity method, net loss 420,000    
Net loss 893,000   5,900,000
Current assets 10,800,000   10,800,000
Total assets 13,000,000.0   13,000,000.0
Current liabilities 1,300,000   1,300,000
Total liabilities $ 2,600,000   2,600,000
Revenues     $ 0